86 related articles for article (PubMed ID: 12133497)
1. [Detection of serum epidermal growth factor receptor in the diagnosis of proliferation of pituitary adenomas].
Kong Y; Ren Z; Su C; Wang R
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):527-9. PubMed ID: 12133497
[TBL] [Abstract][Full Text] [Related]
2. Elevated soluble epidermal growth factor receptor level in pituitary adenoma and carcinoma.
Kong YG; Ren ZY; Su CB; Wang RZ; Ma WB; Lian W
Chin Med Sci J; 2004 Sep; 19(3):199-202. PubMed ID: 15506648
[TBL] [Abstract][Full Text] [Related]
3. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
[TBL] [Abstract][Full Text] [Related]
4. [Measurement of soluble CD44v6 in peripheral blood as assistant diagnosis of invasive pituitary adenomas].
Kong YG; Su CB; Ren ZY; Wang RZ; Li GL; Dou WC; Zhang B; Tian SQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):698-701. PubMed ID: 14714315
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor binding sites in human pituitary macroadenomas.
Jaffrain-Rea ML; Petrangeli E; Lubrano C; Minniti G; Di Stefano D; Sciarra F; Frati L; Tamburrano G; Cantore G; Gulino A
J Endocrinol; 1998 Sep; 158(3):425-33. PubMed ID: 9846172
[TBL] [Abstract][Full Text] [Related]
6. Pre- and post-operative hypothalamic-pituitary-thyroidal axis function in patients with prolactinoma, growth hormone tumour and ACTH tumour.
Lu C; Lin XT; Yang DT; Liu YC; He WT; Zhong XL
Chin Med J (Engl); 1989 Apr; 102(4):306-12. PubMed ID: 2551602
[TBL] [Abstract][Full Text] [Related]
7. [Expressive level of vascular endothelial growth factor in peripheral blood in patients with pituitary adenomas].
Kong YG; Ren ZY; Su CB; Wang RZ; Xing B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):164-7. PubMed ID: 15171554
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness.
LeRiche VK; Asa SL; Ezzat S
J Clin Endocrinol Metab; 1996 Feb; 81(2):656-62. PubMed ID: 8636285
[TBL] [Abstract][Full Text] [Related]
9. Rathke's cleft cysts: differentiation from other cystic lesions in the pituitary fossa by use of single-shot fast spin-echo diffusion-weighted MR imaging.
Kunii N; Abe T; Kawamo M; Tanioka D; Izumiyama H; Moritani T
Acta Neurochir (Wien); 2007 Aug; 149(8):759-69; discussion 769. PubMed ID: 17594050
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor-binding sites, present in normal human and rat pituitaries, are absent in human pituitary adenomas.
Birman P; Michard M; Li JY; Peillon F; Bression D
J Clin Endocrinol Metab; 1987 Aug; 65(2):275-81. PubMed ID: 3597708
[TBL] [Abstract][Full Text] [Related]
11. [Neurosurgery and pituitary tumors: etio-pathogenic considerations].
Visot A
Presse Med; 2001 Mar; 30(8):392-4. PubMed ID: 11268900
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenoma and concomitant Rathke's cleft cyst.
Noh SJ; Ahn JY; Lee KS; Kim SH
Acta Neurochir (Wien); 2007 Dec; 149(12):1223-8. PubMed ID: 17914599
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome.
Mattogno PP; Mangiola A; Lofrese G; Vigo V; Anile C
Acta Neurochir Suppl; 2017; 124():101-106. PubMed ID: 28120060
[TBL] [Abstract][Full Text] [Related]
14. Lesson to be remembered from a skull base tumor.
Briet C; Bernard F; Rodien P
Neurochirurgie; 2017 Sep; 63(4):334-335. PubMed ID: 28882600
[TBL] [Abstract][Full Text] [Related]
15. 25-hydroxyvitamin D Correlation with Prolactin Levels and Adenoma Size in Female Patients with Newly Diagnosed Prolactin Secreting Adenoma.
Aboelnaga MM; Abdullah N; El Shaer M
Endocr Metab Immune Disord Drug Targets; 2017; 17(3):219-225. PubMed ID: 28595559
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of total removal or subtotal removal combined gamma knife radiation on giant pituitary adenoma: a report of 160 cases].
Xiao QH; Huang SQ; Mao BY; Li GP; Ju Y
Ai Zheng; 2007 Jul; 26(7):742-7. PubMed ID: 17626751
[TBL] [Abstract][Full Text] [Related]
17. [A case of non-functional pituitary adenoma associated with Rathke's cleft cyst].
Kaku S; Tanaka T; Sawauchi S; Dobashi H; Ohtsuka T; Numoto RT; Murakami S; Komine K; Abe T
No Shinkei Geka; 2005 Aug; 33(8):797-803. PubMed ID: 16095210
[TBL] [Abstract][Full Text] [Related]
18. Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts.
McLaughlin N; Cohan P; Barnett P; Eisenberg A; Chaloner C; Kelly DF
World Neurosurg; 2013 Nov; 80(5):569-75. PubMed ID: 22902358
[TBL] [Abstract][Full Text] [Related]
19. Selective excision of adenomas originating in or extending into the pituitary stalk with preservation of pituitary function.
Mason RB; Nieman LK; Doppman JL; Oldfield EH
J Neurosurg; 1997 Sep; 87(3):343-51. PubMed ID: 9285597
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
